Not applicableUnknownNCT03058198What this trial is testingThe Research on 89Zr-ABT806 PET Imaging in High Grade GliomaWho this might be right forGlioma Huashan Hospital 40
Very early researchNot Yet RecruitingNCT07244666What this trial is testingSafety and Preliminary Efficacy of a Metabolically Armed Chimeric Antigen Receptor T Cell Therapy Targeting EGFRvIII for Recurrent GlioblastomaWho this might be right forGlioblastoma (GBM) Second Affiliated Hospital, Zhejiang University, School of Medicine 36
Testing effectiveness (Phase 2)Study completedNCT01520870What this trial is testingSafety and Efficacy of PF-299804 (Dacomitinib), a Pan-HER Irreversible Inhibitor, in Patients With Recurrent Glioblastoma With EGFR Amplification or Presence of EGFRvIII Mutation. A Phase II CT.Who this might be right forGlioblastomaBrain Tumor, Recurrent Grupo Español de Investigación en Neurooncología 49
Testing effectiveness (Phase 2)Study completedNCT01454596What this trial is testingCAR T Cell Receptor Immunotherapy Targeting EGFRvIII for Patients With Malignant Gliomas Expressing EGFRvIIIWho this might be right forMalignant GliomaGlioblastomaBrain Cancer+1 more National Cancer Institute (NCI) 18
Testing effectiveness (Phase 2)UnknownNCT03941626What this trial is testingAutologous CAR-T/TCR-T Cell Immunotherapy for Solid MalignanciesWho this might be right forEsophagus CancerHepatomaGlioma+1 more Shenzhen BinDeBio Ltd. 50
Early research (Phase 1)Looking for participantsNCT07480941What this trial is testingDual-Targeting CAR-NK Cells for Recurrent/Progressive Glioblastoma and High-Grade GliomaWho this might be right forGlioblastomaHigh-grade GliomaMalignant Glioma+2 more Beijing Biotech 36
Testing effectiveness (Phase 2)Study completedNCT01498328What this trial is testingRindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive GlioblastomaWho this might be right forGlioblastomaSmall Cell GlioblastomaGiant Cell Glioblastoma+4 more Celldex Therapeutics 127
Early research (Phase 1)Study completedNCT01967758What this trial is testingPhase I Study of Safety and Immunogenicity of ADU-623Who this might be right forAstrocytic TumorsGlioblastoma MultiformeAnaplastic Astrocytoma+1 more Providence Health & Services 11
Large-scale testing (Phase 3)Study completedNCT01480479What this trial is testingPhase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed GlioblastomaWho this might be right forGlioblastomaSmall Cell GlioblastomaGiant Cell Glioblastoma+2 more Celldex Therapeutics 745
Early research (Phase 1)Study completedNCT01475006What this trial is testingAMG 595 First-in-Human in Recurrent GliomasWho this might be right forAdvanced Malignant GliomaAnaplastic AstrocytomasGlioblastoma Multiforme Amgen 32
Testing effectiveness (Phase 2)WithdrawnNCT02432417What this trial is testingThe Addition of Chloroquine to Chemoradiation for Glioblastoma,Who this might be right forGlioblastomaAstrocytoma, Grade IV Maastricht Radiation Oncology
Early research (Phase 1)UnknownNCT05063682What this trial is testingThe Efficacy and Safety of Brain-targeting Immune Cells (EGFRvIII-CAR T Cells) in Treating Patients With Leptomeningeal Disease From Glioblastoma. Administering Patients EGFRvIII -CAR T Cells May Help to Recognize and Destroy Brain Tumor Cells in PatientsWho this might be right forGlioblastomaGlioblastoma MultiformeGlioma, Malignant Chembrain LTD 10
Large-scale testing (Phase 3)Study completedNCT02573324What this trial is testingABT-414 in Participants With Newly Diagnosed Glioblastoma (GBM) With Epidermal Growth Factor Receptor (EGFR) AmplificationWho this might be right forGlioblastomaGliosarcoma AbbVie 691